Our recent study has shown that down-regulated DDX3 levels are correlated with high tumor grade and poor prognosis in HCC patients, and its reduction causes down-regulation of tumor-suppressive miR-12225. This evidence concerns the gene DDX3X and hepatocellular carcinoma.